Information Provided By: 
Fly News Breaks for May 1, 2017
INVA
May 1, 2017 | 08:03 EDT
Cowen analyst Tyler Van Buren said the recent earnings miss at Innoviva was largely non-fundamental and impacted by pressures that he expects will reverse in Q2. He said prescriptions look great and he views the weakness in Innoviva shares as a buying opportunity. Van Buren reiterated his Outperform rating and $16 price target on Innoviva shares.
News For INVA From the Last 2 Days
